HIGHLIGHTS
SUMMARY
By monitoring multiple hospitals in specific areas. The ADR/ADE cases were matched with non-ADR/ ADE cases in a 1:4 ratio and according to clinical departments, diagnosis, sex, and age. Demographic data for the patients Finally, 11,252 cases (mean age, 55.74 ± 16.20) received ulinastatin for injection, including 7009 (62.29%) ICU cases and 4243 (37.71%) general ward cases. In clinical trials, patients with comorbidities and confounding factors are usually excluded from determining the exact effects of the drug, but such patients will receive the drug in actual Combined . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.